AU2002352357A1 - Trioxane derivatives - Google Patents

Trioxane derivatives

Info

Publication number
AU2002352357A1
AU2002352357A1 AU2002352357A AU2002352357A AU2002352357A1 AU 2002352357 A1 AU2002352357 A1 AU 2002352357A1 AU 2002352357 A AU2002352357 A AU 2002352357A AU 2002352357 A AU2002352357 A AU 2002352357A AU 2002352357 A1 AU2002352357 A1 AU 2002352357A1
Authority
AU
Australia
Prior art keywords
trioxane derivatives
trioxane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352357A
Inventor
Adrian Peter Higson
Edward Irving
Paul Michael O'neill
Sara Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UFC Ltd
Original Assignee
UFC Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0129215.0A external-priority patent/GB0129215D0/en
Priority claimed from GB0217723A external-priority patent/GB0217723D0/en
Application filed by UFC Ltd filed Critical UFC Ltd
Publication of AU2002352357A1 publication Critical patent/AU2002352357A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002352357A 2001-12-06 2002-12-06 Trioxane derivatives Abandoned AU2002352357A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0129215.0A GB0129215D0 (en) 2001-12-06 2001-12-06 Trioxane derivatives
GB0129215.0 2001-12-06
GB0217723.6 2002-07-31
GB0217723A GB0217723D0 (en) 2002-07-31 2002-07-31 Trioxane derivatives
PCT/GB2002/005531 WO2003048167A1 (en) 2001-12-06 2002-12-06 Trioxane derivatives

Publications (1)

Publication Number Publication Date
AU2002352357A1 true AU2002352357A1 (en) 2003-06-17

Family

ID=26246842

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352357A Abandoned AU2002352357A1 (en) 2001-12-06 2002-12-06 Trioxane derivatives

Country Status (5)

Country Link
EP (1) EP1465899A1 (en)
JP (1) JP2005515999A (en)
AU (1) AU2002352357A1 (en)
CA (1) CA2469224A1 (en)
WO (1) WO2003048167A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1814601A (en) * 2005-02-04 2006-08-09 中国科学院上海药物研究所 Artemisine derivative with immune suppression action and medicinal composition
WO2007043057A2 (en) * 2005-10-11 2007-04-19 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US8911751B2 (en) 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
CN102010420B (en) * 2010-10-12 2013-11-27 沈阳药科大学 [(10S)-9,10-dihydroartemisinine-10-oxyl]benzaldehyde semicarbazones (sulfur) series substances as well as preparation method and application thereof
CN102153564B (en) * 2011-01-31 2013-07-24 中国科学院上海药物研究所 Nitrogen-atom-containing arteannuin dimers, and preparation method and application thereof
WO2014023081A1 (en) * 2012-08-07 2014-02-13 中国科学院上海生命科学研究院 Artemisinin derivatives, preparation process and use thereof
CN103113386B (en) * 2013-02-20 2015-12-23 沈阳药科大学 Nitrogen heterocyclic substituted-dihydro artemisinin derivative and application thereof
CN106588950B (en) * 2016-12-13 2018-05-08 昆药集团股份有限公司 artesunate derivative, its preparation method and its application
TW202137978A (en) * 2019-12-26 2021-10-16 日商大日本住友製藥股份有限公司 Method for culturing hematopoietic stem cells
CN112694482B (en) * 2020-12-29 2022-04-01 张家港威胜生物医药有限公司 Method for preparing artesunate by using microchannel reactor
TW202309044A (en) * 2021-04-26 2023-03-01 日商住友製藥股份有限公司 Oxepin derivative
CN115385929A (en) * 2022-09-16 2022-11-25 延边大学 Dihydroartemisinin derivative, preparation method and application

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1041595A (en) * 1988-10-04 1990-04-25 赫彻斯特股份公司 New artemisin derivative, its method for making and as the application of antiprotozoan agent,
CN1028294C (en) * 1989-12-21 1995-04-26 中国科学院上海药物研究所 Containing nitrogen green wormwood element derivative synthetizing and using
CN1038416C (en) * 1992-12-04 1998-05-20 中国科学院上海药物研究所 Artemisin derivant and its preparation method
US5726203A (en) * 1993-07-19 1998-03-10 Li; Zelin Qinghaosu derivatives against AIDS
US5677468A (en) * 1995-06-29 1997-10-14 Hauser, Inc. Artemisinin dimer compounds having anticancer activity
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
CN1084333C (en) * 1998-06-17 2002-05-08 中国科学院上海药物研究所 Artemisine compounds, their preparing process and medicine composition containing them
WO2000004026A1 (en) * 1998-07-14 2000-01-27 The Hong Kong University Of Science & Technology Trioxane derivatives
EP0974594A1 (en) * 1998-07-14 2000-01-26 The Hong Kong University of Science & Technology Artemisinin derivatives as anti-infective agent
US6297272B1 (en) * 1999-01-12 2001-10-02 Hauser, Inc. Artemisinin analogs having antimalarial antiproliferative and antitumor activities and chemoselective methods of making the same
CN1105722C (en) * 1999-11-12 2003-04-16 中国科学院上海药物研究所 Arteannuin derivant containing azacyclic radical and preparation process thereof
AU2001257577A1 (en) * 2000-02-28 2001-09-03 Shearwater Corporation Water-soluble polymer conjugates of artelinic acid

Also Published As

Publication number Publication date
JP2005515999A (en) 2005-06-02
CA2469224A1 (en) 2003-06-12
WO2003048167A1 (en) 2003-06-12
EP1465899A1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002367186A1 (en) Urea derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002362806A1 (en) Pyrimidine derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2002352357A1 (en) Trioxane derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2001288484A1 (en) Novel metallotexaphyrin derivatives
GB0129215D0 (en) Trioxane derivatives
AU2001289782A1 (en) Pyrrolotriazolopyrimidinone derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase